These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18471792)

  • 1. A role for the androgen-receptor in clinically localized and advanced prostate cancer.
    Mohler JL
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):357-72. PubMed ID: 18471792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.
    Titus MA; Zeithaml B; Kantor B; Li X; Haack K; Moore DT; Wilson EM; Mohler JL; Kafri T
    PLoS One; 2012; 7(1):e30192. PubMed ID: 22272301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castration-recurrent prostate cancer is not androgen-independent.
    Mohler JL
    Adv Exp Med Biol; 2008; 617():223-34. PubMed ID: 18497046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy.
    Wikström P; Ohlson N; Stattin P; Bergh A
    Prostate; 2007 Sep; 67(12):1277-84. PubMed ID: 17597113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
    Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
    Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen action and metabolism in prostate cancer.
    Green SM; Mostaghel EA; Nelson PS
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor involvement in the progression of prostate cancer.
    Suzuki H; Ueda T; Ichikawa T; Ito H
    Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor dampens tissue factor expression via nuclear factor-κB and early growth response protein 1.
    Hoesel B; Mussbacher M; Dikorman B; Salzmann M; Assinger A; Hell L; Thaler J; Basílio J; Moser B; Resch U; Paar H; Mackman N; Schmid JA
    J Thromb Haemost; 2018 Apr; 16(4):749-758. PubMed ID: 29427323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrogating androgen receptor function in recurrent prostate cancer.
    Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
    Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal androgen receptor in prostate development and cancer.
    Singh M; Jha R; Melamed J; Shapiro E; Hayward SW; Lee P
    Am J Pathol; 2014 Oct; 184(10):2598-607. PubMed ID: 25088980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens.
    Tamburrino L; Salvianti F; Marchiani S; Pinzani P; Nesi G; Serni S; Forti G; Baldi E
    Steroids; 2012 Aug; 77(10):996-1001. PubMed ID: 22289337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
    Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
    Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor action in hormone-dependent and recurrent prostate cancer.
    Agoulnik IU; Weigel NL
    J Cell Biochem; 2006 Oct; 99(2):362-72. PubMed ID: 16619264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
    Wikström P; Marusic J; Stattin P; Bergh A
    Prostate; 2009 Jun; 69(8):799-809. PubMed ID: 19189305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.
    Leach DA; Trotta AP; Need EF; Risbridger GP; Taylor RA; Buchanan G
    Prostate; 2017 Feb; 77(2):185-195. PubMed ID: 27718274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity.
    Tararova ND; Narizhneva N; Krivokrisenko V; Gudkov AV; Gurova KV
    Prostate; 2007 Dec; 67(16):1801-15. PubMed ID: 17935158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
    Henshall SM; Quinn DI; Lee CS; Head DR; Golovsky D; Brenner PC; Delprado W; Stricker PD; Grygiel JJ; Sutherland RL
    Cancer Res; 2001 Jan; 61(2):423-7. PubMed ID: 11212224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.